
Efficacy of various celecoxib doses versus naproxen and placebo in knee osteoarthritis treatment

Efficacy of various celecoxib doses versus naproxen and placebo in knee osteoarthritis treatment
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial
Mayo Clin Proc. 1999 Nov;74(11):1095-105Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
1003 patients with symptomatic knee osteoarthritis were randomized to be administered either celecoxib 50mg twice daily (b.i.d.), celecoxib 100mg b.i.d., celecoxib 200mg b.i.d., naproxen b.i.d., or placebo. Patients were assessed for efficacy and safety measures over 12 weeks of treatment. Reduction in Western Ontario and McMaster Universities Osteoarthritis Index total scores and OA Severity Inde...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.